share_log

ORGANICELL REGENERATIVE MEDICINE IN | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Chief Executive Officer Leider Harry L.

SEC announcement ·  Dec 21, 2023 16:01
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more